drugset / Trial / NCT00403975

Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease

NCT00403975

Phase 3 Completed 640 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this trial is to assess the effectiveness and safety of 2% diquafosol tetrasodium ophthalmic solution versus placebo following 6 weeks of treatment in subjects with mild to moderate dry eye disease.

Timeline

Start
2004-06
Primary completion
2004-11
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Diquafosol Oligonucleotide (other) 2 % Other

Indications